Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

Pakawat Chongsathidkiet; Christina Jackson; Shohei Koyama; Franziska Loebel; Xiuyu Cui; S Harrison Farber; Karolina Woroniecka; Aladine A Elsamadicy; Cosette A Dechant; Hanna R Kemeny; Luis Sanchez-Perez; Tooba A Cheema; Nicholas C Souders; James E Herndon; Jean-Valery Coumans; Jeffrey I Everitt; Brian V Nahed; John H Sampson; Michael D Gunn; Robert L Martuza; Glenn Dranoff; William T Curry; Peter E Fecci

doi:10.1038/s41591-019-0355-0

Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

Nat Med. 2019 Mar;25(3):529. doi: 10.1038/s41591-019-0355-0.

Authors

Pakawat Chongsathidkiet^{1

2

3}, Christina Jackson⁴, Shohei Koyama⁵, Franziska Loebel⁶, Xiuyu Cui^{1

2}, S Harrison Farber^{1

2

7}, Karolina Woroniecka^{1

2

3}, Aladine A Elsamadicy^{1

2}, Cosette A Dechant^{1

2}, Hanna R Kemeny^{1

2}, Luis Sanchez-Perez^{1

2}, Tooba A Cheema⁸, Nicholas C Souders⁹, James E Herndon¹⁰, Jean-Valery Coumans¹¹, Jeffrey I Everitt³, Brian V Nahed¹¹, John H Sampson^{1

2

3

12

13}, Michael D Gunn^{3

13

14}, Robert L Martuza¹¹, Glenn Dranoff¹⁵, William T Curry¹¹, Peter E Fecci^{16

17

18}

Affiliations

¹ Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
² Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
³ Department of Pathology, Duke University Medical Center, Durham, NC, USA.
⁴ Department of Neurosurgery, The John Hopkins University School of Medicine, Baltimore, MD, USA.
⁵ Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita City, Osaka, Japan.
⁶ Department of Neurosurgery, Charité Medical University, Berlin, Germany.
⁷ Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
⁸ Unum Therapeutics, Cambridge, MA, USA.
⁹ Dana-Farber Cancer Institute, Boston, MA, USA.
¹⁰ Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
¹¹ Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
¹² Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.
¹³ Department of Immunology, Duke University Medical Center, Durham, NC, USA.
¹⁴ Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
¹⁵ Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
¹⁶ Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA. peter.fecci@duke.edu.
¹⁷ Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA. peter.fecci@duke.edu.
¹⁸ Department of Pathology, Duke University Medical Center, Durham, NC, USA. peter.fecci@duke.edu.

Abstract

In the version of this article originally published, the figure callout in this sentence was incorrect: "Furthermore, in S1P1-KI mice themselves, whereas PD-1 blockade was ineffectual as monotherapy, the effects of 4-1BB agonism and checkpoint blockade proved additive, with the combination prolonging median survival and producing a 50% long-term survival rate (Fig. 6f)." The callout should have been to Supplementary Fig. 6b. The error has been corrected in the PDF and HTML versions of the article.

Publication types

Published Erratum

Abstract

Publication types

Grants and funding